Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Sponsor: Vishwajit Nimgaonkar, MD PhD
Summary
This is a double blind adjunctive randomized controlled trial for schizophrenia using cromoglicate.
Official title: Cromoglicte Adjunctive Therapy for Outpatients With Schizophrenia
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2019-04-01
Completion Date
2028-06
Last Updated
2026-03-19
Healthy Volunteers
No
Conditions
Interventions
Cromoglycate
Cromoglycate will be administered intranasally (nasal spray) (1 spray each nostril 4 times a day, 5.2 mg/spray
Placebo
Normal saline nasal spray will be administered intranasally (nasal spray) (1 spray each nostril 4 times a day, 5.2 mg/spray)
Locations (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, United States